First HIV vaccine tested in newborns shows early promise
NCT ID NCT04607408
Summary
This study tested the safety and immune response of an experimental HIV vaccine in healthy infants born to mothers with HIV. The trial enrolled 38 mother-infant pairs, with infants receiving up to five vaccine doses starting in their first week of life. The main goals were to check for side effects and see if the vaccine could trigger an immune response against HIV.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Perinatal HIV Research Unit (PHRU), Soweto CRS
Johannesburg, Gauteng, 1862, South Africa
Conditions
Explore the condition pages connected to this study.